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Infection with schistosomes is accompanied by the induction of antibodies against
the parasite. Despite having IgG against both protein and glycan antigens, infected
individuals remain chronically infected until treated, and re-infection is common
in endemic areas as immunity does not develop effectively. Parasite specific IgG
subclasses may differ in functionality and effectivity with respect to effector functions
that contribute to parasite killing and immunity. In this study, we investigated if
specific IgG subclasses target specific antigenic schistosome glycan motifs during
human infection. Sera from 41 S. mansoni infected individuals from an endemic area
in Uganda were incubated on two glycan microarrays, one consisting of a large
repertoire of schistosome glycoprotein- and glycolipid- derived glycans and the other
consisting of chemically synthesized core xylosylated and fucosylated N-glycans also
expressed by schistosomes. Our results show that highly antigenic glycan motifs,
such as multi-fucosylated terminal GalNAc(β1-4)GlcNAc (LDN) can be recognized by
all IgG subclasses of infection sera, however with highly variable intensities. Detailed
examination of core-modified N-glycan targets revealed individual antibody responses
specific for core-xylosylated and core α3-fucosylated glycan motifs that are life stage
specifically expressed by schistosomes. IgG1 and IgG3 were detected against a range
of N-glycan core structures, but IgG2 and IgG4, when present, were specific for the
core α3-fucose and xylose motifs that were previously found to be IgE targets in
schistosomiasis, and in allergies. This study is the first to address IgG subclass responses
to defined helminth glycans.
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INTRODUCTION
Schistosomiasis is a parasitic infection of humans and mammals contracted by exposure to
schistosome cercariae shed by infected aquatic snails. Once the parasite establishes itself in a
human host, the infection which is associated with debilitating pathology due to tissue-deposition
of eggs remains chronic until treated. In the schistosomiasis endemic areas in Africa,
South-America, and South-East Asia, reinfection after treatment is common. Longitudinal studies
have shown that resistance to re-infection with schistosomes develops very slowly. Many years
of exposure to schistosomes and multiple treatments are required for the immune response to
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become effective (1–3). Various studies have shown that anti-
schistosome antibodies are pivotal for anti-parasite immunity.
Passive immunization with serum or monoclonal antibodies
against schistosome antigens (4–7) were shown to reduce worm
burden and egg production in previously unexposed mice upon
challenge with schistosomes. Moreover, transfer of sera and of
purified IgG from animals immunized with the protective Sm-
p80 antigen conferred resistance to challenge infection, and it has
been shown that the level of protection induced by immunization
with Sm-p80 is reduced in antibody deficient mice (8).
As schistosomes are highly glycosylated organisms that
express many glycan motifs different from mammals, it is not
surprising that an abundance of antibodies are generated against
schistosomal protein- and lipid-linked glycans exposed to the
host (9–14). It is becoming increasingly clear that glycan antigens
play an important role in helminth infection immunology, but
it remains ambiguous whether anti-glycan antibodies contribute
positively or negatively to protection.
Previously we have studied the anti-glycan IgG and IgM
responses in schistosome infected rhesus macaques that are
able to expel the worms (15), in order to identify glycan
targets of antibodies that might be involved in the self-cure
mechanism. We showed that serum IgG antibodies against
highly fucosylated schistosome glycoproteins and glycolipids
formed during infection were sustained when the macaques
cleared the infection, indicating that these antibodies are
present in a protective context and possibly play a role in
the killing of adult worms in the host. Additionally, sera
from macaques containing high titres of IgG against highly
fucosylated motifs were able to kill schistosomula in vitro
(15) and it has been shown that a monoclonal antibody
specific for the fucosylated LeX antigen was protective in a
mouse model of S. mansoni infection (6). On the other hand,
humans that are generally susceptible to reinfection also have
high titres of IgG antibodies against highly fucosylated motifs
(16), indicating that anti-glycan antibodies are not necessarily
protective. Indeed, some studies have regarded schistosome
glycans to form a smokescreen that diverts the host immune
system from attacking vulnerable peptide epitopes that could
mediate protective responses (17–19). It has however been
appreciated that protective glycan epitopes may also occur, but
these could be under-represented and masked by irrelevant or
“smokescreen” epitopes (20). As a consequence, protective anti-
schistosome glycan responses may be difficult to identify. These
observations called for investigations into differential recognition
of specific schistosome glycan motifs in different models and
cohorts such as reported in several recent glycan microarray-
assisted studies (12–16, 21).
Alternatively, research into the IgG subclass-specific response
toward defined glycan antigens may shed light on the role
of anti-glycan antibodies in infection. Perhaps the key to
associate glycan antigens with immunity is not in the antigen
itself, but rather by the type of antibody response generated.
Particular IgG subclasses have been found to correlate with
resistance or susceptibility to schistosome infection: IgG1
against schistosome surface antigens were observed in putatively
resistant individuals in a Brazilian cohort (22), while individuals
that were chronically infected lacked high IgG1 against the same
antigens, but mounted high IgG4 toward various schistosome
antigens instead. IgG4, as well as IgG2 have been found to
correlate with susceptibility of schistosome reinfection (23, 24).
On the other hand, human serum IgG1 and IgG3, as well
as IgE have been found to be potent inducers of eosinophil-
mediated cytotoxicity, while IgG4 antibodies were found to be
inhibiting cytotoxicity (25) and compete with IgE to prevent
antigen cross-linking and IgE mediated effector function (26).
So far, studies on IgG subclass response against schistosome
antigens have focused on schistosome surface proteins (22)
or complex ill-defined schistosome antigen mixtures such as
SEA or AWA (27). Little is known however about IgG
subclass reactivity to defined schistosome glycan antigens.
Interestingly, a recent study has shown that anti-glycan IgE
responses are highly restricted toward only a few specific
epitopes out of the many glycan antigens expressed by
schistosomes, in particular N-glycan core-xylose or core α3-
fucose, motifs that are often associated with plant glycans and
allergens (28).
In the current study, we address the question whether
specific serum IgG subclass responses to defined antigenic
glycans occur during human schistosome infection, and whether
these might be restricted to certain motifs or not. To this
end, we tested the IgG subclass responses in a selection of
41 serum samples from a relatively homogeneous population
in terms of exposure and infection intensity (16, 29) toward
a large collection of schistosome glycan antigens. Using two
glycan microarrays, one comprising a large set of native glycans
isolated from different schistosome life-stages (14–16), the
other comprising a set of synthetic N-glycans with different
core and branch modifications previously described (21) we
determined for each of the IgG subclasses which glycan motifs
are targeted during infection, and evaluated whether these
are different or not for IgG1-4. Our results indicate that
in schistosomiasis sera, each of the IgG subclasses can be
directed against a variety of antigenic glycan motifs, but with
different patterns for the different individuals tested. To our
knowledge, this is the first study that addresses IgG subclass




Sera used in this study were described in an earlier publication
(16) where 41 schistosome infected individuals were selected
from an original cohort study in a highly prevalent S.
mansoni endemic area (29). The cohort study obtained ethical
approval from the Uganda National Council for Science and
Technology (UNCST) and was supported by the Cambridge
Local Research Ethics Committee. Selected subjects had an
age range of 5 to 46 years old, all with patent S. mansoni
infection. The geometric mean of the intensity of infection
measured by egg per gram feces was 560.65 (CI95%: 343.88,
914.05).
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Glycan Microarray Construction And
Incubation
A glycan microarray constructed of glycans derived from S.
mansoni cercariae (75 N-glycan fractions and 102 O-glycan
fractions), adult worms (77 N-glycan fractions and 31 O-glycan
fractions) and eggs (57 egg N-glycan fractions and 98 soluble
egg antigen O-glycan fractions), and 30 glycans derived from
glycosphingolipids representing multiple life stage, was described
previously (14, 16). Twenty-four blank spots with spot buffer
were included for array background control. Each glycan fraction
was immobilized on a glass slide in triplicate. The synthetic
glycan microarray containing a collection of core-xylosylated
and core-α3 and -α6 fucosylated N-glycans with various core
extensions has been described previously (21).
Binding assays of individual or pooled sera on both arrays
were conducted following the protocol as described previously
(14–16). Briefly, the microarray slide was blocked with 2% BSA,
50mM ethanolamine in PBS. Serum samples were diluted 1:100
in PBS-0.01% Tween20 with 1% BSA. All four mouse anti-human
isotype antibodies were purchased from Invitrogen. IgG1 and
IgG3 were labeled with the Promokine PF-647 labeling kit; IgG2
and IgG4 were labeled with the PF-555 labeling kit following the
manufacturer’s protocol. All anti-human IgG subclass antibodies
were diluted 1:200 in PBS-0.01 Tween20 to detect bound serum
antibodies on the slide. All washing steps were performed with
successive rinses with PBS-0.05% Tween20 and with PBS. The
last washing step was finished by an additional wash with milliQ
water and the slides were dried and kept in the dark until
scanning.
Scanning And Data Analysis
A G2565BA scanner (Agilent Technologies, Santa Clara, CA)
was used to scan the slides for fluorescence at 10µm resolution
using lasers at 532 and 633 nm. Anti-IgG2 and anti-IgG4
antibodies were detected at 532 nm and anti-IgG1 and anti-IgG3
antibodies at 633 nm. Data and image analysis was performed
with GenePix Pro 7.0 software (Molecular Devices, Sunnyvale,
CA). Spots were aligned and re-sized using round features with
no CPI threshold. Background-subtracted median intensities
were averaged per time point and processed as described by
Oyelaran et al. (30). Datasets were log2 transformed to remove
the basic trends of variance. A hierarchical clustering analysis
(HCA, complete linkage clustering using Euclidean distance
metric) was performed to group associated glycan fractions using
MultiExperiment Viewer v4.5.
RESULTS
Serum IgG Subclass Response Against
Glycans Expressed by Schistosomes in
Infected Individuals
To investigate whether IgG subclasses in sera from a schistosome-
infected cohort react with specific motifs or subsets of parasite-
associated glycans, we determined IgG1, IgG2, IgG3. and IgG4
binding intensities against a large variety of glycans in pooled
sera of 41 infected individuals using glycan microarrays. These
sera were from a relatively homogeneous population in terms
of exposure and infection intensity). All individuals had patent
S. mansoni infection (geometric mean infection intensity (epg)
was 560.65 (CI95%: 343.88, 914.05). We found that in the pool
IgG of all four subclasses are present against a wide range
of schistosome-derived N-, O-, and glycosphingolipid glycans
printed on the array (Figure 1A). IgG1 and IgG2 bound to
the various glycans with similar high intensities, while anti-
glycan IgG4 binding intensities were lowest out of the four
subclasses. Glycan targets for each of the IgG subclasses consisted
mainly of highly fucosylated LDN epitopes, abundantly expressed
on glycolipid-derived glycans and cercarial O-glycans (31).
Interestingly, IgG subclass binding of N-glycan core xylose
(abundant on glycans from cercariae and miracidia) and core α3-
fucose epitopes (abundant on glycans from eggs and miracidia),
as determined by use of the synthetic glycan array, were rather
different across the four subclasses (Figure 1B). IgG1, IgG3,
and IgG4 in pooled infection serum showed higher binding
intensities to core α3-fucose containing structures than to
structures containing only core-xylose, with IgG4 being restricted
to different subsets of the α3-fucose containing structures.
In contrast, IgG2 response in this pool was mainly directed
toward core xylose containing N-glycans. Core α3-fucose has
been shown to be an antigenic target in schistosome-infected
humans, mice and rhesus macaques (12, 15). Interestingly, alone
or in combination with core xylose, core α3-fucose also forms
the major cross-reactive carbohydrate epitopes that are IgE
targets on a variety of plant-derived allergens (28, 32, 33). To
further analyse the differential reaction of specific IgG subclasses
with core-modified N-glycans, we investigated the IgG subclass
response in each infected individual on the synthetic glycan
array.
Schistosome Infected Individuals
Differentially Express IgG Subclass
Antibodies Toward Schistosome Glycans
Among the individual sera incubated on the synthetic glycan
array a striking variability in IgG subclass response toward
the core-modified glycans was observed (Figure S1). Most sera
contained antibodies binding to core α3-fucose and core xylose
modified N-glycans. However, this was not a universal response
and no clear correlation between IgG subclass and glycan motifs
was observed.
IgG Subclass Response Profile of
Schistosome Infected Individuals
In view of the variations in IgG subclass responses to the
core-modified N-glycans between individuals, we performed
a hierarchical clustering analysis and grouped the individuals
based on response patterns for each IgG subclass (Figure 2A).
We observed a cluster of individuals that had specific and
high IgG1, 2, 3, or 4 binding to core α3-fucose (cluster
red). Another cluster of individuals had high IgG binding
to core xylose containing structures (cluster blue), while the
third cluster, with the highest number of individuals, only had
lower amounts of IgG binding to either core α3-fucose or
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FIGURE 1 | Schistosome infected individuals produce IgG subclass antibodies to schistosome glycans. Averaged serum IgG subclass response from
schistosome-infected individuals to (A) complex N-, O-, and glycoshingolipid glycans isolated from different life stages of schistosomes and (B) core modified
N-glycans synthesized chemically. The horizontal axis indicates different glycan structures. Each bar corresponds to antibody binding to individual glycan fractions
printed on the glycan microarray. Schistosome GSL glycans are shown as a group irrespective of the life stage. N, N-glycans; O, O-glycans; GSL, Glycoshingolipid
derived glycans.
core xylose (cluster yellow). When comparing the IgG subclass
distribution for each motif within each serum, we saw that
some individuals had high binding to core α3-fucose with all
four IgG subclasses (cluster red in all subclasses) (Figure 2B),
while other individuals responded strongly to core α3-fucose
structures with only one or two subclasses that were variably
of the IgG1, 2, 3, or 4 type. Similarly, two individuals of the
41 individuals responded strongly to core xylose containing N-
glycans with all IgG subclasses (cluster blue in all subclasses),
while other individuals responded only with one or two
subclasses, variably of the IgG2, IgG3, or IgG4 class. These
observations indicate that IgG subclass responses toward these
glycan antigens are not restricted by the nature of the antigen,
but rather appear to be related to each individual response to
the infection. One interesting observation was that most of the
individuals that had high IgG subclass response toward either
core xylose or core α3-fucose were children aged 12 or younger
(Figure 2B).
Structural Motifs Bound by IgG1−4
Next, to gain more insight in the structural determinants that
are recognized specifically by the different IgG subclasses, we
examined in detail how the binding of IgG1, IgG2, IgG3,
and IgG4 to core α3-fucose and core xylose is influenced by
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FIGURE 2 | Hierarchical clustering analysis of anti-glycan antibody responses in schistosome infected individuals. (A) Heatmap showing IgG subclass response of
schistosome infected subjects (columns) to core modified N-glycan fractions (rows) that have been synthesized and described by Brzezicka et al. Median
fluorescence intensity was corrected for baseline and log2 transformed; increase in antibody binding is indicated by the red color intensity. Three major clusters of
subjects were identified for each IgG subclass based on antibody binding intensity to glycans: one cluster of individuals had high IgG binding to core α3-fucose (red),
another cluster of individuals to core xylose (blue), and one cluster of individuals without specific binding to core α3-fucose or core xylose (yellow). Core xylosylated
and core α-3 fucosylated structures are indicated. Within core-xylose containing structures, those that have additional monosaccharides on the α-3mannose (1) and
those that miss the core α-6mannose (*) are indicated. (B) IgG subclass response profile of each schistosome infected individual. Red: high response against core
α3-fucose; blue: high response against core xylose; yellow: low response against other glycans. Filled circles (•): age 12 and under. Open circles (◦): age 20 and older.
adjacent structural elements. Comparison of the signal intensities
of four sets of structurally related synthetic glycan structures
first revealed that moderate levels of IgG1 and IgG3 reactive
with the unsubstituted trimannosyl core glycan (Man3GlcNAc2)
(G42) were detected in most sera tested (Figures 3A–C). In
contrast, IgG2 and IgG4 to the N-glycan core were only
detected when either a xylose (G34) or an α3-fucose (G73)
residue were present (Figures 3A,C). Interestingly, IgG1 and
IgG3 in general did not become more reactive upon addition
of core xylose to the trimannosyl core, but signal intensities did
increase significantly upon α3-fucosylation while core α6-fucose
addition (G64) had the opposite effect of lowering the IgG1
and IgG3 response to the otherwise unsubstituted trimannosyl
core. The addition of α6-fucose had no effect on the reactivity
of any of the four IgG subclasses to the α3-fucosylated core
however (G64) (Figure 3C). Regarding the combination of both
the antigenic core xylose and core α3-fucose modifications it
appears that sera where IgG2 and IgG4 reactivity is negative
against core α3-fucose becomes positive upon addition of the
xylose (G37) (Figure 3D). Since reactivity is also observed to
core-xylosylated glycans without fucose, it appears that α3-
fucose and xylose form independent antigenic motifs. Finally,
IgG2 and IgG4, but not IgG1 and IgG3 reactivity against core
xylose are hindered by the addition of a GlcNAc branch to
the 3-linked Man (G5), but removal of the 3-linked Man (G1)
enhances reactivity, indicating that reactivity to xylose depends
on its spatial accessibility (Figures 3A,B). Together these data
suggested that IgG2 and IgG4 reactivity to N-glycan core
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FIGURE 3 | IgG subclass response of schistosome infected individuals to core xylose (A,B) and core α3 fucose (C,D) in the presence or absence of adjacent
structural elements. Median fluorescence intensity was corrected for baseline and log2 transformed. The code for each structure as described in the original
publication (21) is indicated.
structures in schistosomiasis sera are either against the core
xylose and core α3-fucose motifs, whereas IgG1 and IgG3 are less
specific and restricted.
DISCUSSION
In this study we have investigated the IgG subclass responses
against defined parasite-derived glycans in schistosome-infected
individuals. Detailed glycan microarray analysis indicated that
IgG1, 2, 3, and 4 in schistosome infection sera are variably
present against a wide range of antigenic parasite glycans.
Interestingly, individuals infected with schistosomes respond
with particularly high variability to the antigenic α3-fucose
and β2-xylose core modifications of N-glycans with respect
to the different IgG subclasses. This variability in antibody
response was not a reflection of the intensity of infection
as all sera included this study were from heavily infected
individuals living in a schistosome endemic area. The sera
used in this study were selected from a larger study (29),
where selected individuals had an age range between 5 to 46
years old, all with patent S. mansoni infection, with fecal egg
counts between 343.88 and 914.05 epg (CI95% of geometric
mean). Previously, we have used this set of sera to compare
the anti-glycan (total) IgG and IgM in schistosome infected
children and adults (16) and found that although there were
anti-glycan antibody differences between children and adults,
other factors apart from age also played a role in shaping anti-
glycan antibody response profiles. It is well-known that the
overall serum IgG subclass distribution is generally different
between adults and children. IgG1 and IgG3 development is
faster and reaches around 75% of the adult serum levels at
the age of five, while IgG2 and IgG4 levels rise much slower,
reaching 70% of adult serum levels at the age of 14. Nevertheless,
large inter-individual variations were observed previously for
IgG subclass development (34), as corroborated by our study.
Although most individuals with responses of any subclass
toward core modified glycans were children, many children
did not produce antibodies against core modified N-glycans,
raising the question which other factors, possibly cross-reactive
antigens, determine the induction of these schistosome-reactive
antibodies.
The sample selection used here to study the glycan
specificity of IgG subclasses in schistosomiasis infection serum
is not suitable for addressing immunoepidemiological questions.
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Nonetheless, the variable subclass responses to specific glycan
antigens observed in this study may have the potential to reflect
the immune profile of infected individuals and act as markers
for infection with respect to intensity, exposure, chronicity,
immunopathology or resistance to infection. High IgG1 titers
against a specific set of schistosome tegument protein antigens
for instance have been observed in putatively resistant individuals
in a Brazilian cohort but not in chronically infected individuals,
where high IgG4 antibodies against the same schistosome
antigens were observed instead (22). In addition, IgG1 and
IgG3 against protective schistosome antigens has also been
found in naturally resistant individuals but not in chronically
infected or unexposed individuals (35). These studies indicate
the importance of IgG1 against protective antigens in developing
immunity. In contrast, susceptibility to reinfection in humans
has been associated with high levels of IgM, IgG2, and IgG4 (23,
24, 26, 27). The presence of IgM, IgG2, and IgG4, purified from
serum of infected individuals, prevented eosinophil mediated
killing of schistosomula by other IgG subclasses present in
human infection sera (25). The IgG4 subclass is usually produced
after repeated, long-term antigenic stimulation, and has minimal
effector functions. Literature describes highly elevated IgG4
toward schistosome antigens (26) that may compete with IgE
and prevent antigen cross-linking and IgE mediated effector
functions. Interestingly, although we have not observed very
high IgG4 binding intensities against schistosome glycans,
precisely the core α3-fucose and core xylose motifs that form
the cross-reactive carbohydrate determinants for IgE in plant
allergens as well as helminths (28, 33, 36) are also the only
IgG4 reactive glycan elements in the tested N-glycans in the
current study. It should be noted that expression of core α3-
fucose and core xylose motifs during the schistosome life cycles
appears to be highly specific. By mass spectrometric glycomics
approaches it has been shown that core xylose is abundant on
N-glycans of cercariae and miracidia (31), whereas core α3-
fucose has been detected in abundance in N-glycans on the
secretory egg glycoproteins IPSE/α1 (37) and omega-1 (together
with core α6-fucose) (38) and on N-glycans derived from
the miracidia (31) and the egg glycoprotein kappa-5 (together
with α6-fucose and core xylose) (39). Both core xylose and
core α3-fucose are expressed by plant glycoproteins (33, 40)
and in a small subset of other helminths (36). The specific
IgG determined in our study may therefore also have been
triggered by other antigen sources other than schistosomes. It
would be interesting to investigate the IgG subclass response of
infected individuals toward more complex glycan antigens that
are schistosome specific, such as highly fucosylated LDN epitopes
on glycoproteins and glycosphingolipids of the parasite and its
secretions. Such complex schistosome antigens, induce higher
total IgG binding in schistosome infected rhesus macaques
compared to core modified epitopes (15). Given that highly
fucosylated motif such as Fucα1-2Fucα1-3 on LDN have not
been found in organisms other than schistosomes, it would be
interesting to see if different individuals would have a less variable
IgG subclass distribution to these complex, more parasite-specific
glycan antigens, when these would become available as synthetic,
defined antigens.
In this study we have for the first time investigated
the IgG subclass response against schistosome glycans in
infected individuals. The complex interplay between how
antigens trigger IgG subclass response calls for analysis
with a larger human cohort with better defined resistant
and susceptible immune profiles, to be able to understand
whether particular subclasses against particular glycan epitopes
are associated with a disease state. Although high inter-
individual antibody variation was observed against core modified
N-glycans expressed by schistosomes, IgG subclass response
against complex antennae schistosome glycans remain to be
elucidated.
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